November/December 2004


In this Issue

Glaucoma Today


The Effect of Topical Glaucoma Medication on the Efficacy of SLT

Could SLT be considered an outflow drug?

By Mark A. Latina, MD, and John Mark S. de Leon, MD

Racial Differences in the Optic Nerve

Efforts to detect early glaucoma.

By Christopher A. Girkin, MD

Capsular Tension Devices for the Glaucoma Surgeon

Approaching cases of zonular weakness.

By Iqbal Ike K. Ahmed, MD, and Michael Butler, MD

Communicating Effectively With Glaucoma Patients

Focusing on dialogue and education can improve treatment.

By Thomas E. Bournias, MD

Debate: Does Race Matter in Glaucoma?

Viewpoint No. 1: Considering this factor promotes the more effective treatment of patients.

By Alan L. Robin, MD

5 Questions With Don Minckler, MD

By Don Minckler, MD

The Nerve Fiber Layer and Scanning Laser Polarimetry

The history and utility of this technology.

By Robert D. Fechtner, MD

Debate: Does Race Matter in Glaucoma?

Viewpoint No. 2: This factor is mutable and therefore not important.

By Eve J. Higginbotham, MD

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.